GAL-021

GAL-021
Clinical data
Routes of
administration
Intravenous
Legal status
Legal status
Identifiers
PubChem (CID) 57340959
Chemical and physical data
Formula C11H22N6O
Molar mass 254.331 g/mol
3D model (Jmol) Interactive image

GAL-021 is a drug related to almitrine which acts as a respiratory stimulant, with its mechanism of action primarily thought to involve blocking the BKCa potassium channel,[1] although secondary mechanisms may also be involved.[2] It was developed by Galleon Pharmaceuticals, and is being tested in clinical trials for potential uses in post-operative care,[3] as well as more generally to counteract the respiratory depression which can be a side effect of opioid analgesic drugs.[4][5][6]

See also

References

  1. McLeod JF, Leempoels JM, Peng SX, Dax SL, Myers LJ, Golder FJ. GAL-021, a new intravenous BKCa-channel blocker, is well tolerated and stimulates ventilation in healthy volunteers. Br J Anaesth. 2014 Nov;113(5):875-83. doi: 10.1093/bja/aeu182 PMID 24989775
  2. Santhosh M Baby, Toshinori Hoshi, Sean Peng, Scott L Dax, Francis J Golder, D Euan MacIntyre and James C Mannion. Comparison of the respiratory effects of GAL-021 in BK α subunit knockout (Slo1–/ –) and wild-type mice. FASEB Journal. April 2012 26 (Meeting Abstract Supplement) 704.30
  3. Golder FJ, Hewitt MM, McLeod JF. Respiratory stimulant drugs in the post-operative setting. Respir Physiol Neurobiol. 2013 Nov 1;189(2):395-402. doi: 10.1016/j.resp.2013.06.010 PMID 23791825
  4. Santhosh M Baby, Ryan B Gruber, Veljko Puskovic, Sean Peng, Scott L Dax, Francis J Golder, D Euan MacIntyre and James C Mannion. GAL-021, a novel respiratory stimulant, attenuates opioid–induced respiratory depression without compromising analgesia. FASEB Journal. April 2012 26 (Meeting Abstract Supplement) 704.28
  5. van der Schier R, Roozekrans M, van Velzen M, Dahan A, Niesters M. Opioid-induced respiratory depression: reversal by non-opioid drugs. F1000Prime Rep. 2014 Sep 4;6:79. doi: 10.12703/P6-79. PMID 25343036
  6. Roozekrans M, van der Schrier R, Okkerse P, Hay J, McLeod JF, Dahan A. Two studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human volunteers. Anesthesiology. 2014 Sep;121(3):459-68. doi: 10.1097/ALN.0000000000000367 PMID 25222672


This article is issued from Wikipedia - version of the 6/18/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.